Can lower doses of ibrutinib still control CLL? new trial aims to find out
NCT ID NCT05963074
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 4 times
Summary
This phase 2 study is testing whether adjusting the dose of ibrutinib—either by starting lower or reducing it when side effects occur—can still effectively control chronic lymphocytic leukemia (CLL) in people who have not yet been treated. Some participants will receive ibrutinib alone, while others will get ibrutinib combined with venetoclax. The goal is to see if these customized regimens maintain disease control while being easier to tolerate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ibrutinib and venetoclax
- What this could lead to
- If successful, this could show that adjusting ibrutinib doses based on side effects is as effective as standard dosing, making treatment more tolerable for CLL patients.
- What could go wrong
- This is a phase 2 trial with 320 participants, so results are still preliminary. The dose adjustments might reduce effectiveness or fail to improve tolerability as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASST Grande Ospedale Metropolitano Niguarda
Milan, 20162, Italy
-
Azienda Ospedaliera di Perugia Ospedale S.Maria della Misericordia
Perugia, 06132, Italy
-
Azienda Ospedaliero Universitaria Careggi
Florence, 50134, Italy
-
Azienda Ospedaliero-Universitaria di Ferrara Arcispedale Sant Anna
Ferrara, 44124, Italy
-
Boise VA Medical Center
Boise, Idaho, 83702, United States
-
CHU Lyon Sud
Pierre-Bénite, 69495, France
-
CHU Nantes
Nantes, 44000, France
-
CHU de Clermont Ferrand
Clermont-Ferrand, 63100, France
-
CHU de Reims
Reims, 51100, France
-
Cancer and Blood Specialty Clinic
Los Alamitos, California, 90720, United States
-
Centrum Onkologii Ziemi Lubelskiej im sw Jana z Dukli
Lublin, 20 090, Poland
-
Community Cancer Trials of Utah
Ogden, Utah, 84405, United States
-
Ematologia Fondazione Univ. Policlinico Gemelli Università Cattolica del Sacro Cuore
Roma, 00136, Italy
-
Fakultni Nemocnice Ostrava
Ostrava - Poruba, 708 52, Czechia
-
Fakultni nemocnice Brno
Brno-Bohunice, 625 00, Czechia
-
Fakultni nemocnice Hradec Kralove
Hradec Králové, 500 05, Czechia
-
Fakultni nemocnice Kralovske Vinohrady
Prague, 100 34, Czechia
-
Fakultni nemocnice Olomouc
Olomouc, 779 00, Czechia
-
Grand Valley Oncology
Grand Junction, Colorado, 81505, United States
-
Gyor Moson Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz
Győr, 9024, Hungary
-
Hematology Oncology Associates of Rockland
Nyack, New York, 10960, United States
-
Hope and Healing Cancer Services
Hinsdale, Illinois, 60521, United States
-
Hopital Pitie Salpetriere
Paris, 75651, France
-
Hosp Reina Sofia
Córdoba, 14004, Spain
-
Hosp Univ Vall D Hebron
Barcelona, 08035, Spain
-
Hosp. Clinico Univ. de Santiago
Santiago de Compostela, 15706, Spain
-
Hosp. Univ. 12 de Octubre
Madrid, 28041, Spain
-
Hosp. Univ. Marques de Valdecilla
Santander, 39008, Spain
-
Hosp. Univ. Ramon Y Cajal
Madrid, 28034, Spain
-
Hunterdon Hematology Oncology
Flemington, New Jersey, 08822, United States
-
Institut de Cancerologie Strasbourg Europe ICANS
Strasbourg, 67200, France
-
Iowa City VA Health Care System
Iowa City, Iowa, 52246, United States
-
Mid Florida Hematology Oncology
Orange, Florida, 32763, United States
-
Minnesota Oncology Hematology P A
Minneapolis, Minnesota, 55404, United States
-
Mount Sinai Medical Center Campus
Miami Beach, Florida, 33140-2948, United States
-
Niagara Health System
St. Catharines, Ontario, L2S 0A9, Canada
-
Northwest Cancer Specialists PC
Vancouver, Washington, 98684, United States
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
-
Oncology Hematology Care
Cincinnati, Ohio, 45242, United States
-
Ospedale Maggiore della Carita
Novara, 28100, Italy
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Ospedale Villa Sofia-Cervello
Palermo, 90146, Italy
-
PIH Health Hospital
Whittier, California, 90602, United States
-
Providence Medical Foundation
Santa Rosa, California, 95403, United States
-
QEII Health Sciences Centre
Halifax, Nova Scotia, B3H 1V7, Canada
-
Renovatio Clinical
El Paso, Texas, 79915, United States
-
Renovatio Clinical 1
The Woodlands, Texas, 77380, United States
-
Research Medical Center
Kansas City, Missouri, 64132, United States
-
SLO Oncology and Hematology Health Center
San Luis Obispo, California, 93401, United States
-
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie
Krakow, 30 688, Poland
-
Semmelweis Egyetem
Budapest, 1088, Hungary
-
Southeastern Medical Oncology Center
Goldsboro, North Carolina, 27534, United States
-
Springfield Clinic
Springfield, Illinois, 62702, United States
-
Summit Medical Group
Florham Park, New Jersey, 07932, United States
-
Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach
Kielce, 25 734, Poland
-
Szabolcs Szatmar Bereg Varmegyei Oktatokorhaz
Nyíregyháza, 4400, Hungary
-
Szpital Specjalistyczny w Brzozowie
Brzozów, 36 200, Poland
-
Szpitale Pomorskie Sp z o o
Gdynia, 81-519, Poland
-
Texas Oncology-Fort Worth Cancer Center
Fort Worth, Texas, 76104, United States
-
Texas Oncology-Gulf Coast
The Woodlands, Texas, 77380, United States
-
The Oncology Institute
North Miami Beach, Florida, 33169, United States
-
The Oncology Institute Clinical Research
Cerritos, California, 90703, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
U.O. Ematologia Istituto Tumori Giovanni Paolo II
Bari, 70124, Italy
-
Umberto I Policlinico di Roma
Roma, 00161, Italy
-
Universita degli Studi di Padova Azienda Ospedaliera di Pa
Padova, 35129, Italy
-
University of Szeged
Szeged, 6725, Hungary
-
Ustav Hematologie A Krevni Transfuze
Prague, 128 00, Czechia
-
VA Puget Sound Healthcare System
Seattle, Washington, 98108, United States
-
Virginia Cancer Specialists
Manassas, Virginia, 20110, United States
-
Virginia Oncology Associates
Virginia Beach, Virginia, 23456, United States
-
Willamette Valley Cancer Institute and Research Center
Eugene, Oregon, 97401, United States
-
Wojewodzki Szpital Specjalistyczny
Biała Podlaska, 21 500, Poland
-
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im M Kopernika w Lodzi
Lodz, 93 513, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug combo outsmart High-Risk CLL?
- Can a gentler dose of zanubrutinib keep CLL at bay in the very elderly?
- Can a Two-Drug combo wipe out hidden leukemia cells?
- New biologic MK-1045 targets Hard-to-Treat blood cancers
- New transplant recipe aims to tame Graft-Versus-Host disease
- Can a tailored exercise and diet plan beat cancer fatigue?